NTAP
39
-2
CMCSA
52
6
NOC
47
2
COP
48
-2
ABT
60
-5
KHC
38
-4
HSIC
57
-2
BDX
57
2
ADBE
33
-4
CNX
59
4
CHD
54
-2
JNJ
57
3
DVN
32
3
GD
52
2
MNST
65
2
GRMN
40
-5
MTCH
46
-5
AN
38
-2
ADT
50
2
EFX
77
16
NTAP
39
-2
CMCSA
52
6
NOC
47
2
COP
48
-2
ABT
60
-5
KHC
38
-4
HSIC
57
-2
BDX
57
2
ADBE
33
-4
CNX
59
4
CHD
54
-2
JNJ
57
3
DVN
32
3
GD
52
2
MNST
65
2
GRMN
40
-5
MTCH
46
-5
AN
38
-2
ADT
50
2
EFX
77
16
Financhill
Back

Ultra Clean Holdings Vs. Monopar Therapeutics Industry Stock Comparison

Sell
34

UCTT
Ultra Clean Holdings

Last Price:
$24.86
Seasonality Move:
8.12%
Sell
45

MNPR
Monopar Therapeutics

Last Price:
$34.55
Seasonality Move:
-24.75%
Sell
34
Ultra Clean Holdings (UCTT) is a Sell

Is Ultra Clean Holdings a Buy, Sell or Hold?

  • The current Ultra Clean Holdings [UCTT] share price is $24.91. The Score for UCTT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UCTT Stock Price Chart

What is Ultra Clean Holdings's stock price today?

  • The Ultra Clean Holdings share price today is $24.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $34.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

UCTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 36.49 Sell
Chaikin Money Flow: -297878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.43 - 36.55) Sell
Bollinger Bands (100): (30.47 - 39.65) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 50.93 Buy
Chaikin Money Flow: 16181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.38 - 44.94) Sell
Bollinger Bands (100): (16.76 - 38.26) Buy

UCTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.6 Buy
20-day SMA: 28.05 Sell
50-day SMA: 33.57 Sell
200-day SMA: 38.64 Sell
8-day EMA: 25.06 Sell
20-day EMA: 27.55 Sell
50-day EMA: 31.63 Sell
200-day EMA: 36.36 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.92 Buy
20-day SMA: 34.11 Buy
50-day SMA: 35.31 Sell
200-day SMA: 15.6 Buy
8-day EMA: 32.1 Buy
20-day EMA: 33.86 Buy
50-day EMA: 33.39 Buy
200-day EMA: 20.23 Buy

Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

Ultra Clean Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):